COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

May 31, 2020

Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: a report from the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP)

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
A Rubio-San-SimónF Bautista
June 1, 2020

Appropriate arrangement of cancer treatment after COVID-19 epidemic peaks in China

Journal of Cancer Research and Clinical Oncology
Hongnan MoFei Ma
May 31, 2020

Predictors for Severe COVID-19 Infection

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Ashish BhargavaLouis Saravolatz
May 31, 2020

Cytokine storm in COVID-19 and parthenolide: preclinical evidence

Phytotherapy Research : PTR
Mohsen BahramiMajid Dadmehr
May 31, 2020

Speeding tumor genotyping during the SARS-CoV-2 outbreak through liquid biopsy

Christian RolfoDiego de Miguel-Pérez
June 1, 2020

Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort

The Lancet. HIV
Pilar VizcarraCOVID-19 ID Team
May 31, 2020

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

Bertrand CariouCORONADO investigators
June 1, 2020

Cancer in intensive care unit patients with COVID-19

The Journal of Infection
Sergey MoiseevVictor Fomin
May 31, 2020

Cancer treatment during COVID-19 pandemic

Medical Oncology
Vishal JindalIshmael Jaiyesimi
May 31, 2020

COVID-19 and diabetes: Is there enough evidence?

The Journal of Clinical Hypertension
Marijana TadicCarla Sala
June 1, 2020

Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?

Diabetes & Metabolic Syndrome
Awadhesh Kumar Singh, Ritu Singh
June 1, 2020

Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic

Trends in Cardiovascular Medicine
Sarju GanatraFrederic S Resnic

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

COVID-19 Immunopathology

The research highlighted in this feed investigates the immunopathology seen in severely ill COVID-19 patients, which often resembles the cytokine storm syndrome: uncontrolled immune activation generates excessive release of cytokines, resulting in hyperinflammation and multi-organ disease.

COVID-19 Neurologic Manifestations

COVID-19 patients frequently have neurological symptoms, which are probably caused by the virus invading the central nervous system. Symptoms range from a loss of smell and taste to serious complications such as encephalitis, many of which are associated with poor prognosis. This feed follows the latest developments and research into the neurological complications associated with COVID-19.

© 2020 Meta ULC. All rights reserved